|
1
|
Hu C, Tkebuchava T and Hu D: Managing
acute myocardial infarction in China. Eur Heart J. 40:1179–1181.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reed GW, Rossi JE and Cannon CP: Acute
myocardial infarction. Lancet. 389:197–210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang CJ, Chen PC, Lin CS, Tsai CL and Tsai
SH: Thrombolytic therapy-associated acute myocardial infarction in
patients with acute ischemic stroke: A treatment dilemma. Am J
Emerg Med. 35:804.e1–804.e3. 2017. View Article : Google Scholar
|
|
4
|
Kassimis G and Picard F: Resorbable
magnesium scaffolds in acute myocardial infarction patients: ‘To be
or not to be’? Cardiology. 142:97–99. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hoeke G, Wang Y, van Dam AD, Mol IM, Gart
E, Klop HG, van den Berg SM, Pieterman EH, Princen HMG, Groen AK,
et al: Atorvastatin accelerates clearance of lipoprotein remnants
generated by activated brown fat to further reduce
hypercholesterolemia and atherosclerosis. Atherosclerosis.
267:116–126. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McCarthy CP, Vaduganathan M, McCarthy KJ,
Januzzi JL Jr, Bhatt DL and McEvoy JW: Left ventricular thrombus
after acute myocardial infarction: Screening, prevention, and
treatment. JAMA Cardiol. 3:642–649. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma Y, Kong L, Qi S and Wang D:
Atorvastatin blocks increased l-type Ca2+ current and
cell injury elicited by angiotensin II via inhibiting oxide stress.
Acta Biochim Biophys Sin (Shanghai). 48:378–384. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gavazzoni M, Gorga E, Derosa G, Maffioli
P, Metra M and Raddino R: High-dose atorvastatin versus moderate
dose on early vascular protection after ST-elevation myocardial
infarction. Drug Des Devel Ther. 11:3425–3434. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Q, Zhao YG, Wang Z, Jiang HP, Liu WB
and Cao BF: Effects of first high-dose atorvastatin loading in
patients with ST-segment elevation myocardial infarction undergoing
percutaneous coronary intervention. Am J Ther. 25:e291–e298. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu XR, Li KB, Wang P, Xu L, Liu Y, Yang ZS
and Yang XC: The impact of different doses of atorvastatin on
plasma endothelin and platelet function in acute ST-segment
elevation myocardial infarction after emergency percutaneous
coronary intervention. Zhonghua Nei Ke Za Zhi. 55:932–936. 2016.(In
Chinese). PubMed/NCBI
|
|
11
|
Koyasu S, Kobayashi M, Goto Y, Hiraoka M
and Harada H: Regulatory mechanisms of hypoxia-inducible factor 1
activity: Two decades of knowledge. Cancer Sci. 109:560–571. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang N, Chen J, Ferraro GB, Wu L, Datta
M, Jain RK, Plotkin SR, Stemmer-Rachamimov A and Xu L: Anti-VEGF
treatment improves neurological function in tumors of the nervous
system. Exp Neurol. 299:326–333. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cheng C, Li P, Wang YG, Bi MH and Wu PS:
Study on the expression of VEGF and HIF-1α in infarct area of rats
with AMI. Eur Rev Med Pharmacol Sci. 20:115–119. 2016.PubMed/NCBI
|
|
14
|
Parisi Q, Biondi-Zoccai GG, Abbate A,
Santini D, Vasaturo F, Scarpa S, Bussani R, Leone AM, Petrolini A,
Silvestri F, et al: Hypoxia inducible factor-1 expression mediates
myocardial response to ischemia late after acute myocardial
infarction. Int J Cardiol. 99:337–339. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eyarefe OD, Ologunagba FM and Emikpe BO:
Wound healing potential of natural honey in diabetic and
non-diabetic wistar rats. Afr J Biomed Res. 17:15–21. 2014.
|
|
16
|
Helft G, Georges JL, Mouranche X, Loyeau
A, Spaulding C, Caussin C, Benamer H, Garot P, Livarek B, Teiger E,
et al e-MUST and CARDIO-ARSIF Registries, : Outcomes of primary
percutaneous coronary interventions in nonagenarians with acute
myocardial infarction. Int J Cardiol. 192:24–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen WW, Gao RL, Liu LS, Zhu ML, Wang W,
Wang YJ, Wu ZS, Li HJ, Gu DF, Yang YJ, et al: China cardiovascular
diseases report 2015: A summary. J Geriatr Cardiol. 14:1–10.
2017.PubMed/NCBI
|
|
18
|
Yamamoto K, Sakakura K, Akashi N, Watanabe
Y, Noguchi M, Seguchi M, Taniguchi Y, Ugata Y, Wada H, Momomura SI,
et al: Novel acute myocardial infarction risk stratification (nARS)
system reduces the length of hospitalization for acute myocardial
infarction. Circ J. 83:1039–1046. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mensah K, Mocanu MM and Yellon DM: Failure
to protect the myocardium against ischemia/reperfusion injury after
chronic atorvastatin treatment is recaptured by acute atorvastatin
treatment: A potential role for phosphatase and tensin homolog
deleted on chromosome ten? J Am Coll Cardiol. 45:1287–1291. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Du ZB, Mao RM, Gao WM, Mi L, Cao ZP and
Zhu BL: Early expression of hypoxia-inducible factor-1 alpha after
acute myocardial ischemia in rats. Fa Yi Xue Za Zhi. 28:327–332.
2012.(In Chinese). PubMed/NCBI
|
|
21
|
Chen Y, Tao Y, Zhang L, Xu W and Zhou X:
Diagnostic and prognostic value of biomarkers in acute myocardial
infarction. Postgrad Med J. 95:210–216. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li M, Cui Y, He W, Deng X, Wang Y, Cai M,
Wang Y, Pei J, Mei X and Wu P: Effects of triple-mutated
hypoxia-inducible factor-1α on angiogenesis and cardiac function
improvement in rats with myocardial infarction. Cell Physiol
Biochem. 50:2329–2340. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang L, Yang J, Zheng J and Gu X: Acute
myocardial infarction in pregnancy: Spasm caused by
hyperthyroidism? J Int Med Res. 47:2269–2273. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sivri N, Tekin G, Yalta K, Aksoy Y, Senen
K and Yetkin E: Statins decrease mean platelet volume irrespective
of cholesterol lowering effect. Kardiol Pol. 71:1042–1047. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nordøy A, Svensson B and Hansen JB:
Atorvastatin and omega-3 fatty acids protect against activation of
the coagulation system in patients with combined hyperlipemia. J
Thromb Haemost. 1:690–697. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Otto CM: Heartbeat: Improving acute
myocardial infarction outcomes in women. Heart. 105:501–502. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang M, Vaez M, Dorner TE, Rahman S,
Helgesson M, Ivert T and Mittendorfer-Rutz E: Risk factors for
subsequent work disability in patients with acute myocardial
infarction. Eur J Public Health. 29:531–540. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kumar M, Rehan HS, Puri R, Yadav M and
Gupta LK: Randomized controlled trial comparing the efficacy of
daily and every other day atorvastatin therapy and its correlation
with serum hydroxymethylglutaryl-CoA reductase enzyme levels in
naïve dyslipidemic patients. Indian Heart J. 70 (Suppl 3):S64–S67.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Komarova IS, Karova LB, Andreeva NV,
Cherkasova NA and Zhelnov VV: Effect of myocardial reperfusion on
ischemic mitral regurgitation in patients with acute myocardial
infarction. Kardiologiia. 59:18–25. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ielasi A, Cerrato E, Geraci S, Campo G,
Garro N, Leoncini M, Sganzerla P, Granata F, Ruggiero R, Varbella
F, et al: Sirolimus-eluting magnesium resorbable scaffold
implantation in patients with acute myocardial infarction.
Cardiology. 142:93–96. 2019. View Article : Google Scholar : PubMed/NCBI
|
